BAVA Bavarian Nordic A/S

New Incentive Program Established for Members of Executive Management and Selected Employees in Bavarian Nordic

New Incentive Program Established for Members of Executive Management and Selected Employees in Bavarian Nordic

COPENHAGEN, Denmark, December 13, 2024 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Board of Directors has decided to establish a new long-term incentive program for Executive Management and selected employees in the Bavarian Nordic Group. Members of the Executive Management are granted a mix of performance restricted stock units (Performance RSUs) and warrants, both subject to the successful achievement of relevant Key Performance Indicators (KPI’s). Employees participating in the program are granted warrants only. The decision is made in accordance with the shareholder authorizations for the Board of Directors adopted as Articles 5b of the Articles of Association and the Remuneration Policy.

A total of 118,274 warrants are granted to members of Executive Management with a subscription price of DKK 198.90 per share equivalent to the market price of Bavarian Nordic's shares at the time of grant. Furthermore, a total of 46,700 Performance RSUs are granted to members of Executive Management. The combined value of warrants and Performance RSUs granted to each member of Executive Management equals up to 100% of their fixed annual base wage. The Performance RSUs will vest in three years from the date of grant, provided that all vesting conditions have been met. Vesting of the warrants and Performance RSUs is subject to prior fulfilment of KPI's as determined by the Board of Directors.

A total of 1,053,509 warrants are granted to selected employees in the Bavarian Nordic Group with a subscription price of DKK 223.33 per share, determined as the average market price (closing price) of the Company's shares on Nasdaq Copenhagen over a period of 15 business days prior to grant plus 15 %.

Collectively, under the new warrant programs a total of 1,171,783 warrants are granted, which entitle the holders to subscribe for up to 1,171,783 shares in total with a nominal value of DKK 10 each. Vested warrants may be exercised wholly or partly during eight fixed subscription periods during 2028 and 2029, however subject to predefined caps on the maximum value of the exercise for each individual warrant holder at the time of exercise as laid out in the Remuneration Policy.

Calculated on the Black-Scholes model and adjusted for the historic probability of achievement of KPI’s, the theoretical value of each warrant granted to members of Executive Management equals DKK 76.68. The Black-Scholes value of each warrant granted to selected employees equals DKK 75.33. The calculations are based on a share price of DKK 198.90, a risk-free interest rate of 1.65 per cent and on the historical volatility of the shares in relevant peers.

The value of each Performance RSU granted to the members of Executive Management equals DKK 194.20 determined as the average market price (closing price) of the Company's shares on Nasdaq Copenhagen over a period of 15 business days prior to grant.

About Bavarian Nordic

Bavarian Nordic is a global vaccine company with a mission to improve health and save lives through innovative vaccines. We are a preferred supplier of mpox and smallpox vaccines to governments to enhance public health preparedness and have a leading portfolio of travel vaccines. For more information, visit

Forward-looking statements

This announcement includes forward-looking statements that involve risks, uncertainties and other factors, many of which are outside of our control, that could cause actual results to differ materially from the results discussed in the forward-looking statements. Forward-looking statements include statements concerning our plans, objectives, goals, future events, performance and/or other information that is not historical information. All such forward-looking statements are expressly qualified by these cautionary statements and any other cautionary statements which may accompany the forward-looking statements. We undertake no obligation to publicly update or revise forward-looking statements to reflect subsequent events or circumstances after the date made, except as required by law.

Contacts

Europe: Rolf Sass Sørensen, Vice President Investor Relations, , Tel:

US: Graham Morrell, Paddock Circle Advisors, , Tel:

Company Announcement no. 39 / 2024

Attachment



EN
13/12/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Bavarian Nordic A/S

 PRESS RELEASE

Bavarian Nordic offentliggør foreløbige resultater for 2025 og forvent...

Bavarian Nordic offentliggør foreløbige resultater for 2025 og forventninger til 2026 Resultatet overgår de seneste forventninger til 2025 efter en stærk udvikling i begge kommercielle forretningsben, Travel Health og Public Preparedness.Forventningerne til 2026 afspejler en fortsat vækst i Travel Health (10% fra egne produkter, 14% i konstant valuta) og et normaliseret år inden for Public Preparedness, begge områder i overensstemmelse med selskabets offentliggjorte vækstambitioner på mellemlang sigt. KØBENHAVN, Danmark, 12. februar 2026 – Bavarian Nordic A/S (OMX: BAVA) offentliggjorde i ...

 PRESS RELEASE

Bavarian Nordic Reports Preliminary 2025 Financial Results and Provide...

Bavarian Nordic Reports Preliminary 2025 Financial Results and Provides Guidance for 2026 Exceeding latest 2025 guidance following a strong performance from both commercial arms of the business in Travel Health and Public Preparedness.2026 guidance reflects continued growth in Travel Health (10% from own products, 14% at constant exchange rates) and a normalized year in Public Preparedness, both in line with the communicated mid-term growth ambitions. COPENHAGEN, Denmark, February 12, 2026 – Bavarian Nordic A/S (OMX: BAVA) today announced preliminary, unaudited financial results for 2025 a...

 PRESS RELEASE

Bavarian Nordic – afslutning af aktietilbagekøbsprogram

Bavarian Nordic – afslutning af aktietilbagekøbsprogram KØBENHAVN, Danmark, 9. februar 2026 – Bavarian Nordic A/S (OMX: BAVA) meddeler, at aktietilbagekøbsprogrammet, der blev offentliggjort og iværksat den 7. januar 2026, nu er afsluttet, da aktier til en samlet værdi af ca. DKK 150 mio. er tilbagekøbt som planlagt. Dette udgjorde den første del af et samlet planlagt aktietilbagekøb på op til DKK 500 mio. i løbet af 2026. Bavarian Nordic vil beholde de tilbagekøbte aktier som egne aktier med det formål at tilpasse kapitalstrukturen. Programmet blev gennemført i overensstemmelse med bestem...

 PRESS RELEASE

Bavarian Nordic – Completion of Share Buy-Back Program

Bavarian Nordic – Completion of Share Buy-Back Program COPENHAGEN, Denmark, February 9, 2026 – Bavarian Nordic A/S (OMX: BAVA) announces that the share buy-back program, which was announced and initiated on January 7, 2026, has now been completed, reaching an aggregate amount of approximately DKK 150 million as planned. This represented the first tranche of a total planned share buy-back of up to DKK 500 million in 2026. Bavarian Nordic will hold the shares bought back as treasury stock, for the purpose of adjusting the capital structure. The program was executed in accordance with Regulat...

 PRESS RELEASE

Bavarian Nordic – transaktioner i forbindelse med aktietilbagekøbsprog...

Bavarian Nordic – transaktioner i forbindelse med aktietilbagekøbsprogram KØBENHAVN, Danmark, 2. februar 2026 – Bavarian Nordic A/S (OMX: BAVA) offentliggør transaktioner under aktietilbagekøbsprogrammet, der blev iværksat den 7. januar 2026, hvorunder selskaber vil tilbagekøbe aktier for op til DKK 150 mio. i perioden fra den 7. januar 2026 til den 13. februar 2026. Programmet gennemføres i overensstemmelse med bestemmelserne i Europa-Parlamentets og Rådets forordning (EU) nr. 596/2014 (ændret) om markedsmisbrug og den delegerede forordning (EU) nr. 2016/1052, der samlet udgør Safe Harbour...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch